| Dennis Shaw Dpm | |
|
4201 Medical Center Dr Ste 290, Mckinney, TX 75069-1765 | |
| (972) 548-0002 | |
| (972) 562-5556 |
| Full Name | Dennis Shaw Dpm |
|---|---|
| Type | Facility |
| Speciality | Durable Medical Equipment & Medical Supplies |
| Location | 4201 Medical Center Dr Ste 290, Mckinney, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730365008 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 613 (Texas) | Secondary |
| 332B00000X | Durable Medical Equipment & Medical Supplies | 613 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dennis Shaw Dpm 4201 Medical Center Dr Ste 290, Mckinney, TX 75069-1765 Ph: (972) 548-0002 | Dennis Shaw Dpm 4201 Medical Center Dr Ste 290, Mckinney, TX 75069-1765 Ph: (972) 548-0002 |
News Archive
Congenital heart disease is the most common birth defect. And even with remarkable advances in care, it remains the leading cause of non-infectious death in infants.
Children with Cushing syndrome may be at higher risk for suicide as well as for depression, anxiety and other mental health conditions long after their disease has been successfully treated, according to a study by researchers at the National Institutes of Health.
Amgen today announced that the U.S. Food and Drug Administration (FDA) approved two new indications for Prolia® (denosumab) as a treatment to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer and as a treatment to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for non-metastatic prostate cancer.
Gene Security Network, Inc (GSN) today announced that Human Reproduction published results validating the exceptional performance of GSN's proprietary Parental SupportTM technology over existing methods to detect chromosome abnormalities during in vitro-fertilization (IVF).
Clear goals, strong leadership and infrastructure, staff engagement, and transparent reporting methods are key for complex health care systems seeking to establish successful patient safety performance improvements, according to a Johns Hopkins study published in the journal Academic Medicine in December.
› Verified 8 days ago